van den Bent MJ - Search Results

1

Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective.

van den Bent MJ. van den Bent MJ. Acta Neuropathol. 2010 Sep;120(3):297-304. doi: 10.1007/s00401-010-0725-7. Epub 2010 Jul 20. Acta Neuropathol. 2010. PMID: 20644945 Free PMC article. Review.

2

Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration.

Hilkens PH, van der Burg ME, Moll JW, Planting AS, van Putten WL, Vecht CJ, van den Bent MJ. Hilkens PH, et al. Among authors: van putten wl, van den bent mj, van der burg me. Eur J Cancer. 1995;31A(5):678-81. doi: 10.1016/0959-8049(94)00497-s. Eur J Cancer. 1995. PMID: 7640038 Clinical Trial.

3

The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.

Straathof CS, van den Bent MJ, Ma J, Schmitz PI, Kros JM, Stoter G, Vecht CJ, Schellens JH. Straathof CS, et al. Among authors: van den bent mj. J Neurooncol. 1998 Mar;37(1):1-8. doi: 10.1023/a:1005835212246. J Neurooncol. 1998. PMID: 9525832

4

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

van den Bent MJ, Kros JM, Heimans JJ, Pronk LC, van Groeningen CJ, Krouwer HG, Taphoorn MJ, Zonnenberg BA, Tijssen CC, Twijnstra A, Punt CJ, Boogerd W. van den Bent MJ, et al. Among authors: van groeningen cj. Neurology. 1998 Oct;51(4):1140-5. doi: 10.1212/wnl.51.4.1140. Neurology. 1998. PMID: 9781544

5

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.

van den Bent MJ, Schellens JH, Vecht CJ, Sillevis Smit PA, Loosveld OJ, Ma J, Tijssen CC, Jansen RL, Kros JM, Verweij J. van den Bent MJ, et al. Eur J Cancer. 1998 Sep;34(10):1570-4. doi: 10.1016/s0959-8049(98)00138-5. Eur J Cancer. 1998. PMID: 9893630 Clinical Trial.

6

Leptomeningeal metastasis after surgical resection of brain metastases.

van der Ree TC, Dippel DW, Avezaat CJ, Sillevis Smitt PA, Vecht CJ, van den Bent MJ. van der Ree TC, et al. Among authors: van den bent mj. J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):225-7. doi: 10.1136/jnnp.66.2.225. J Neurol Neurosurg Psychiatry. 1999. PMID: 10071105 Free PMC article.

7

Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.

Luider TM, Kros JM, Sillevis Smitt PA, van den Bent MJ, Vecht CJ. Luider TM, et al. Among authors: van den bent mj. Electrophoresis. 1999 Apr-May;20(4-5):1087-91. doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<1087::AID-ELPS1087>3.0.CO;2-6. Electrophoresis. 1999. PMID: 10344289

8

The accumulation of topotecan in 9L glioma and in brain parenchyma with and without dexamethasone administration.

Straathof CS, van den Bent MJ, Loos WJ, Vecht CJ, Schellens JH. Straathof CS, et al. Among authors: van den bent mj. J Neurooncol. 1999 Apr;42(2):117-22. doi: 10.1023/a:1006166716683. J Neurooncol. 1999. PMID: 10421068

9

Chemotherapy in adult malignant glioma.

van den Bent MJ. van den Bent MJ. Front Radiat Ther Oncol. 1999;33:174-91. doi: 10.1159/000061234. Front Radiat Ther Oncol. 1999. PMID: 10549488 Review. No abstract available.

10

Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma.

van den Bent MJ, Pronk L, Sillevis Smitt PA, Vecht CJ, Eskens FA, Verweij J. van den Bent MJ, et al. J Neurooncol. 1999 Aug;44(1):59-64. doi: 10.1023/a:1006201909435. J Neurooncol. 1999. PMID: 10582670 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results